Subclinical hyperthyroidism is a condition where your thyroid is slightly overactive, but not enough to push your thyroid hormone levels outside the normal range. It’s detected through blood work: your TSH (thyroid-stimulating hormone) level is low or undetectable, while your T4 and T3 hormone levels remain normal. About 3.2% of U.S. adults have it, and many don’t realize it because symptoms can be subtle or absent entirely.
How It Shows Up on Blood Tests
A normal TSH level for a non-pregnant adult falls between 0.4 and 4.5 mIU/L. In subclinical hyperthyroidism, TSH drops below that range while T4 and T3 stay normal. This is the key distinction from overt hyperthyroidism, where those hormone levels are also elevated.
The condition is classified into two grades based on how low TSH drops:
- Mild: TSH is low but still detectable, usually between 0.1 and 0.4 mIU/L.
- Severe: TSH falls below 0.1 mIU/L.
That distinction matters because the severe form carries higher risks for your heart and bones, and is more likely to require treatment.
Common Causes
The causes fall into two broad categories: your thyroid producing too much hormone on its own, or an outside source of thyroid hormone tipping the balance.
Among internal causes, Graves’ disease is the most common in the United States and most Western countries. It’s an autoimmune condition where your immune system stimulates the thyroid to overproduce. In older adults and in regions where iodine intake is low, a toxic multinodular goiter (an enlarged thyroid with multiple overactive nodules) is more often the culprit. A single overactive thyroid nodule, called a toxic adenoma, is another possibility.
The most common external cause is taking too much thyroid hormone medication. People on levothyroxine for an underactive thyroid or after thyroid surgery can end up with suppressed TSH if their dose is slightly too high. In some cases, the suppression is intentional, particularly after treatment for thyroid cancer, where doctors deliberately keep TSH low to reduce the chance of recurrence.
Symptoms You Might Notice
Many people with subclinical hyperthyroidism feel perfectly fine, which is why it’s often caught incidentally on routine blood work. When symptoms do appear, they tend to be mild versions of what you’d see in full-blown hyperthyroidism: a slightly faster heart rate, occasional palpitations, mild anxiety, difficulty sleeping, or a subtle tremor in the hands.
There’s also a cognitive dimension. Research has found that people with subclinical hyperthyroidism can experience reduced executive function, slower psychomotor speed, and difficulty sustaining attention. These changes are subtle enough that you might chalk them up to stress or aging rather than a thyroid issue. The intensity of depressive symptoms in these patients also correlates with worse performance on cognitive tests, suggesting the effects can compound each other.
Cardiovascular Risks
The most significant concern with subclinical hyperthyroidism is its effect on the heart. Even mildly suppressed TSH increases the workload on the cardiovascular system over time. A large meta-analysis found that people with subclinical hyperthyroidism have roughly double the risk of developing atrial fibrillation compared to people with normal thyroid function. That’s a 99% increase in risk, which is substantial, especially for older adults who already face higher baseline odds of irregular heart rhythms.
This elevated risk is a major reason doctors take the severe form (TSH below 0.1 mIU/L) seriously, even when someone feels well. Atrial fibrillation increases the risk of stroke and heart failure, so preventing it is a priority.
Effects on Bone Health
Thyroid hormones play a direct role in bone turnover. When the thyroid runs hot, bone breakdown accelerates without a matching increase in bone formation. In subclinical hyperthyroidism, this effect is more modest than in overt disease, but it accumulates. A large analysis published in JAMA Network Open found that people with subclinical hyperthyroidism had a 34% higher risk of fractures compared to those with normal thyroid function, even after adjusting for factors like menopause status.
This is particularly relevant for postmenopausal women, who are already losing bone density due to declining estrogen. Adding even a mild thyroid excess on top of that can meaningfully accelerate bone loss.
Does It Always Get Worse?
Not necessarily. Subclinical hyperthyroidism resolves on its own in a meaningful number of cases, particularly when the TSH suppression is mild. Among those whose condition does progress, about 8% develop overt hyperthyroidism within one year, and roughly 26% progress within five years. The likelihood of progression depends on the underlying cause: an autonomous thyroid nodule or Graves’ disease is more likely to worsen than a temporary fluctuation caused by thyroiditis or a brief medication adjustment.
Because of this variability, doctors typically repeat thyroid blood tests after two to three months before making any treatment decisions. A single low TSH reading doesn’t necessarily mean you have a persistent problem.
When Treatment Is Considered
Treatment decisions hinge on the severity of TSH suppression, your age, and whether you have other risk factors. The two grades of the condition are managed quite differently.
For the severe form, where TSH is below 0.1 mIU/L, treatment is generally recommended for adults over 65 because of the heightened risk of atrial fibrillation and bone loss. For younger adults with severe suppression, treatment is considered if there are symptoms, heart disease, osteoporosis, or other risk factors.
For the mild form (TSH between 0.1 and 0.4 mIU/L), the approach is more conservative. Monitoring with periodic blood tests is often sufficient, especially in younger people without symptoms. If the cause is thyroid medication, the fix is straightforward: adjusting the dose.
When treatment of an overactive thyroid itself is needed, the options are the same as for overt hyperthyroidism: anti-thyroid medication, radioactive iodine therapy, or, less commonly, surgery. The choice depends on the underlying cause and your individual circumstances.